[go: up one dir, main page]

WO2006117885A8 - 皮膚外用剤 - Google Patents

皮膚外用剤 Download PDF

Info

Publication number
WO2006117885A8
WO2006117885A8 PCT/JP2005/017681 JP2005017681W WO2006117885A8 WO 2006117885 A8 WO2006117885 A8 WO 2006117885A8 JP 2005017681 W JP2005017681 W JP 2005017681W WO 2006117885 A8 WO2006117885 A8 WO 2006117885A8
Authority
WO
WIPO (PCT)
Prior art keywords
skin
external preparation
amelioration
excellent effect
aminolevulinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2005/017681
Other languages
English (en)
French (fr)
Other versions
WO2006117885A1 (ja
Inventor
Yoshiyasu Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/912,433 priority Critical patent/US20090130227A1/en
Priority to KR1020077027153A priority patent/KR100929264B1/ko
Priority to JP2006536992A priority patent/JP3991063B2/ja
Priority to CA2606140A priority patent/CA2606140C/en
Priority to EP05787723.5A priority patent/EP1878421B1/en
Priority to NZ562874A priority patent/NZ562874A/en
Priority to PL05787723T priority patent/PL1878421T3/pl
Priority to MX2007013623A priority patent/MX2007013623A/es
Priority to CN200580049628XA priority patent/CN101166510B/zh
Application filed by Individual filed Critical Individual
Priority to AU2005331416A priority patent/AU2005331416B2/en
Priority to BRPI0520076A priority patent/BRPI0520076B1/pt
Publication of WO2006117885A1 publication Critical patent/WO2006117885A1/ja
Publication of WO2006117885A8 publication Critical patent/WO2006117885A8/ja
Priority to IL186871A priority patent/IL186871A/en
Anticipated expiration legal-status Critical
Priority to NO20076019A priority patent/NO341897B1/no
Priority to US12/945,177 priority patent/US9333156B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　肌荒れ、乾燥肌、皮膚のしわ、たるみ、しみの予防・改善、角質のターンオーバー改善等の美肌効果及びアトピー性皮膚炎等の皮膚疾患の改善効果に優れた、５－アミノレブリン酸類を有効成分とする皮膚外用剤を提供するものである。５－アミノレブリン酸若しくはその塩、又はそれらの誘導体から選ばれる１種又は２種以上の化合物と鉄化合物とを有効成分として含有することを特徴とする皮膚外用剤を用いる。
PCT/JP2005/017681 2005-04-28 2005-09-27 皮膚外用剤 Ceased WO2006117885A1 (ja)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CN200580049628XA CN101166510B (zh) 2005-04-28 2005-09-27 皮肤外用剂
JP2006536992A JP3991063B2 (ja) 2005-04-28 2005-09-27 皮膚外用剤
AU2005331416A AU2005331416B2 (en) 2005-04-28 2005-09-27 External preparation for skin
EP05787723.5A EP1878421B1 (en) 2005-04-28 2005-09-27 External preparation for skin
NZ562874A NZ562874A (en) 2005-04-28 2005-09-27 A combination of 5-aminolevuline or a derivative and an iron compound for treating skin conditions
PL05787723T PL1878421T3 (pl) 2005-04-28 2005-09-27 Preparat do stosowania zewnętrznego na skórę
MX2007013623A MX2007013623A (es) 2005-04-28 2005-09-27 Preparacion externa para la piel.
US11/912,433 US20090130227A1 (en) 2005-04-28 2005-09-27 External preparation for skin
CA2606140A CA2606140C (en) 2005-04-28 2005-09-27 External preparation for skin
KR1020077027153A KR100929264B1 (ko) 2005-04-28 2005-09-27 피부외용제
BRPI0520076A BRPI0520076B1 (pt) 2005-04-28 2005-09-27 preparação externa para pele, drogas preventivas/melhoradoras para aspereza de pele, para pele seca, e para rugas/manchas, métodos para prevenir/melhorar aspereza de pele, pele seca, e rugas/manchas, droga melhoradora de dermatite atópica, método para melhorar dermatite atópica, e, conjunto de preparações externas para pele
IL186871A IL186871A (en) 2005-04-28 2007-10-23 External preparation for use on the skin
NO20076019A NO341897B1 (no) 2005-04-28 2007-11-22 Preparat for behandling og/eller forbedring av en hudsykdom
US12/945,177 US9333156B2 (en) 2005-04-28 2010-11-12 External preparation for skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-131171 2005-04-28
JP2005131171 2005-04-28

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/912,433 A-371-Of-International US20090130227A1 (en) 2005-04-28 2005-09-27 External preparation for skin
US12/945,177 Division US9333156B2 (en) 2005-04-28 2010-11-12 External preparation for skin

Publications (2)

Publication Number Publication Date
WO2006117885A1 WO2006117885A1 (ja) 2006-11-09
WO2006117885A8 true WO2006117885A8 (ja) 2006-12-21

Family

ID=37307691

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/017681 Ceased WO2006117885A1 (ja) 2005-04-28 2005-09-27 皮膚外用剤

Country Status (16)

Country Link
US (2) US20090130227A1 (ja)
EP (1) EP1878421B1 (ja)
JP (1) JP3991063B2 (ja)
KR (1) KR100929264B1 (ja)
CN (1) CN101166510B (ja)
AU (1) AU2005331416B2 (ja)
BR (1) BRPI0520076B1 (ja)
CA (1) CA2606140C (ja)
IL (1) IL186871A (ja)
MX (1) MX2007013623A (ja)
NO (1) NO341897B1 (ja)
NZ (2) NZ587597A (ja)
PL (1) PL1878421T3 (ja)
RU (1) RU2381022C2 (ja)
WO (1) WO2006117885A1 (ja)
ZA (1) ZA200708438B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9247802B2 (en) 2005-08-12 2016-02-02 Tcms Transparent Beauty Llc System and method for medical monitoring and treatment through cosmetic monitoring and treatment
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
WO2008100880A1 (en) 2007-02-12 2008-08-21 Yeager Rick B System and method for applying agent electrostatically to human skin
JP5098051B2 (ja) * 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
EP2272538B1 (en) 2008-04-22 2020-09-02 SBI Pharmaceuticals Co., Ltd. Method of detecting bladder cancer
KR101601669B1 (ko) * 2008-05-14 2016-03-09 에스비아이 파마 가부시키가이샤 남성 불임 치료제
WO2009145348A1 (ja) * 2008-05-30 2009-12-03 Ｊｆｅスチール株式会社 銑鉄製造方法
JP5295652B2 (ja) * 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
JP5081121B2 (ja) * 2008-10-17 2012-11-21 株式会社ミルボン 育毛剤組成物
CA2935654C (en) 2008-10-27 2019-01-08 Sbi Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, its ester, or salt thereof as active ingredient
WO2011145343A1 (ja) 2010-05-19 2011-11-24 Ｓｂｉアラプロモ株式会社 ５－アミノレブリン酸又はその誘導体を有効成分とする抗マラリア薬
CN104411306B (zh) * 2012-07-13 2017-05-24 思佰益药业股份有限公司 免疫耐受诱导剂
CN103054736B (zh) * 2013-01-05 2015-07-15 陕西佰美基因股份有限公司 一种含有血红素的抗衰老化妆品
RU2538084C1 (ru) * 2013-07-25 2015-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздрава России) Средство для лечения и профилактики атопического дерматита
KR101654028B1 (ko) * 2015-02-17 2016-09-05 제너럴바이오(주) 피부 도포용 화장료 조성물 및 이의 제조방법
US10933010B2 (en) 2015-05-11 2021-03-02 Hayashibara Co., Ltd. External dermal agent
ES2981753T3 (es) * 2017-02-06 2024-10-10 3Skin As Composición de filtro solar
KR20210011964A (ko) * 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
BR102019005545A2 (pt) * 2019-03-21 2020-10-06 Natbio Ltda Me Formulações cosméticas constituídas por uma mistura nutritiva proveniente de um processo fermentativo
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN114081851A (zh) * 2021-11-01 2022-02-25 苏州纳美特生物科技有限公司 保湿喷雾
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259318A (en) * 1978-03-02 1981-03-31 University Of Houston, Central Campus Poison ivy relief composition
JPS58152805A (ja) * 1982-03-06 1983-09-10 Masayuki Shirai 温泉水含有皮膚化粧料
JP2694756B2 (ja) 1988-08-19 1997-12-24 有限会社アイ・ビー・イー 二価三価鉄塩配合化粧品
JPH02108612A (ja) * 1988-10-19 1990-04-20 Shizen:Kk 二価三価複合鉄塩配合化粧品
JP2767318B2 (ja) 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
JP2747644B2 (ja) 1993-08-19 1998-05-06 株式会社コスモ総合研究所 植物成長調節剤
JPH09509403A (ja) * 1993-12-15 1997-09-22 エイボン プロダクツ インコーポレイテッド 新規なレチノイド共役体化合物及び皮膚老化を処置するための方法
JPH0881322A (ja) 1994-09-16 1996-03-26 Mitsui Toatsu Chem Inc 微生物雑草防除組成物
GB9510162D0 (en) * 1995-05-19 1995-07-12 Bouras Elias Compositions for the treatment of skin conditions
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
JP3644809B2 (ja) 1997-10-15 2005-05-11 コスモ石油株式会社 頭部用外用剤
JP3948588B2 (ja) 1998-03-05 2007-07-25 株式会社資生堂 皮膚バリアー機能回復促進剤
JP2000281556A (ja) 1999-03-29 2000-10-10 Shiseido Co Ltd 皮膚外用剤
JP3970492B2 (ja) * 1999-12-14 2007-09-05 コスモ石油株式会社 ピーリング用組成物
NO20002428D0 (no) * 2000-05-10 2000-05-10 Radiumhospitalets Forskningsst Hudpreparat
JP2002020294A (ja) 2000-06-30 2002-01-23 Lion Corp 皮膚外用剤
FR2811563B1 (fr) * 2000-07-13 2003-06-20 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
JP2002179518A (ja) * 2000-12-14 2002-06-26 Kyowa Hakko Kogyo Co Ltd 化粧料
US6565864B2 (en) * 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
ITMI20010685A1 (it) * 2001-03-30 2002-09-30 Biochimici Psn S P A Acido delta-amminolevulinico per uso medico e cosmetico
JP4754731B2 (ja) * 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
EP1312353A1 (en) * 2001-11-16 2003-05-21 Ecole Polytechnique Federale De Lausanne (Epfl) Method for hair removal
AT410633B (de) * 2002-04-25 2003-06-25 Oekopharm Forschungs Und Entwi Verwendung eines auf einer biologisch inerten, hochdispersen matrix getrockneten stutenmilchkonzentrats
US20030212127A1 (en) * 2002-05-09 2003-11-13 Bradley Pharmaceuticals, Inc. Method of treating actinic keratosis
DE20213787U1 (de) * 2002-09-04 2002-12-19 Warner-Lambert Co., Morris Plains, N.J. Hautpflegemittel
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
JP4425554B2 (ja) 2003-03-19 2010-03-03 日本メナード化粧品株式会社 皮膚外用剤
US7258875B2 (en) * 2003-12-04 2007-08-21 Chiou Consulting, Inc. Compositions and methods for topical treatment of skin infection
BRPI0418784B1 (pt) 2004-04-28 2014-08-19 Cosmo Oil Co Ltd Composição restauradora de cabelo, e, método não-terapêutico para restaurar cabelo

Also Published As

Publication number Publication date
ZA200708438B (en) 2008-09-25
BRPI0520076A2 (pt) 2009-08-18
BRPI0520076B1 (pt) 2018-05-08
EP1878421B1 (en) 2019-04-03
IL186871A0 (en) 2008-06-05
KR20080003916A (ko) 2008-01-08
US20090130227A1 (en) 2009-05-21
CN101166510B (zh) 2012-03-07
NZ562874A (en) 2010-09-30
US9333156B2 (en) 2016-05-10
NO341897B1 (no) 2018-02-12
NO20076019L (no) 2008-01-28
AU2005331416A1 (en) 2006-11-09
RU2007143517A (ru) 2009-06-10
CA2606140C (en) 2011-07-19
NZ587597A (en) 2011-11-25
EP1878421A4 (en) 2015-11-18
US20110060042A1 (en) 2011-03-10
JP3991063B2 (ja) 2007-10-17
CA2606140A1 (en) 2006-11-09
CN101166510A (zh) 2008-04-23
KR100929264B1 (ko) 2009-12-01
IL186871A (en) 2015-08-31
JPWO2006117885A1 (ja) 2008-12-18
EP1878421A1 (en) 2008-01-16
WO2006117885A1 (ja) 2006-11-09
MX2007013623A (es) 2008-02-12
PL1878421T3 (pl) 2019-09-30
RU2381022C2 (ru) 2010-02-10
AU2005331416B2 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
WO2006117885A8 (ja) 皮膚外用剤
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2005113553A3 (de) Azinyl-imidazoazine und azinylcarboxamide
WO2007067495A3 (en) Levodopa prodrug mesylate, compositions thereof, and uses thereof
WO2007133865A3 (en) Hcv/hiv inhibitors an their uses
WO2008073332A3 (en) Creatine compositions for skin treatment
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
WO2006099943A8 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2009041663A1 (ja) 皮膚疾患の予防及び／または治療剤
WO2011021892A3 (ko) 헥사미딘류 및 레티노이드류를 함유하는 피부 개선 조성물
WO2007053844A8 (en) Compositions and methods for treating inflammatory disorders
WO2008061990A3 (en) Cosmetic composition comprising a proline derivative and/or a salt of the said derivative
WO2009011305A1 (ja) アミド化合物とその植物病害防除方法
WO2006003492A3 (en) Compositions and methods for treating pathological infections
TW200724166A (en) Wrinkle-improving agent
WO2009107853A3 (en) Agent for preventing or ameliorating skin aging
AU2005313582A8 (en) Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer&#39;s disease
WO2004073675A8 (de) Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
WO2006123031A3 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l&#39;etat solubilise
WO2007031883A3 (en) Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof
JP2004315386A5 (ja)
WO2006105482A3 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
WO2008111296A1 (ja) 角化の亢進に起因する皮膚疾患の予防及び治療のための医薬
WO2009074498A8 (en) Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006536992

Country of ref document: JP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005331416

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 7765/DELNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 12007502253

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2005787723

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 186871

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 11912433

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2606140

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 562874

Country of ref document: NZ

Ref document number: 200580049628.X

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: MX/a/2007/013623

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

ENP Entry into the national phase

Ref document number: 2005331416

Country of ref document: AU

Date of ref document: 20050927

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005331416

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020077027153

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2007143517

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2005787723

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0520076

Country of ref document: BR

Kind code of ref document: A2